MPWT
VKTX icon

MassMutual Private Wealth & Trust’s Viking Therapeutics VKTX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Sell
10,629
-40
-0.4% -$1.29K 0.01% 337
2026
Q1 		$347K Buy
10,669
+44
+0.4% +$1.41K 0.01% 356
2025
Q4 		$374K Buy
10,625
+10,200
+2,400% +$361K 0.01% 345
2025
Q3 		$11.2K Hold
425
– – ﹤0.01% 1348
2025
Q2 		$11.3K Sell
425
-130
-23% -$3.42K ﹤0.01% 1310
2025
Q1 		$13.4K Buy
555
+98
+21% +$3.1K ﹤0.01% 1183
2024
Q4 		$18.4K Sell
457
-96
-17% -$5.47K ﹤0.01% 1040
2024
Q3 		$35K Buy
553
+253
+84% +$14.8K ﹤0.01% 765
2024
Q2 		$15.9K Sell
300
-10
-3% -$656 ﹤0.01% 923
2024
Q1 		$25.4K Buy
+310
New +$13.8K ﹤0.01% 767
2023
Q4 		– Sell
-49
Closed -$542 – 2103
2023
Q3 		$542 Buy
+49
New +$701 ﹤0.01% 1802

Other funds holding VKTX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return

MassMutual Private Wealth & Trust's VKTX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Viking Therapeutics (VKTX) stake by 0.37% in Q2 2026, selling an estimated $1.29K and leaving 10,629 shares worth $415K. The position accounts for 0.01% of the portfolio, ranked #337.

MassMutual Private Wealth & Trust first reported a position in VKTX in Q3 2023 and has held it in 11 quarters since. 136 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • MassMutual Private Wealth & Trust held 10,629 shares of Viking Therapeutics worth $415K as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 40 Viking Therapeutics shares in Q2 2026, an estimated $1.29K.
  • Viking Therapeutics made up 0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #337 holding.
  • MassMutual Private Wealth & Trust first reported a position in Viking Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • 136 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.